COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03258034
Recruitment Status : Enrolling by invitation
First Posted : August 22, 2017
Last Update Posted : August 22, 2017
Zhejiang Cancer Hospital
Fujian Cancer Hospital
Information provided by (Responsible Party):
The First Affiliated Hospital of Zhejiang Chinese Medical University

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : August 22, 2020
Estimated Study Completion Date : October 22, 2021